INO   $0.375  7.68% Market Closed

Inovio Pharmaceuticals Inc
Total Cash 145.29M
totalCashPerShare 6.217
EBITDA -130.66M
Total Debt 30.21M
quickRatio 3.47
currentRatio 3.597
Total Revenue 832.01K
debtToEquity 25.743
Revenue/Share 0.038
ROA -0.32106
ROE -0.79547995
grossProfits
freeCashflow -86.15M
operatingCashflow -124.37M
earningsGrowth
revenueGrowth -0.177
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -266.86288
profitMargins 0.0
enterpriseValue 209.30M
forwardPE -4.094395
floatShares 22.99M
sharesOutstanding 23.37M
sharesShort 2.06M
sharesShortPriorMonth 1.74M
dateShortInterest
sharesPercentSharesOut 0.09%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.18%
Short Ratio help_outline 3.52%
shortPercentOfFloat 0.09%
impliedSharesOutstanding
bookValue 5.148
Price To Book help_outline 2.70
earningsQuarterlyGrowth
netIncomeToCommon -135.12M
trailingEps -6.09%
forwardEps -3.39%
enterpriseToEbitda -1.60
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.99 1Q 2024
institutionsCount 131
lastUpdated April 1, 2024, 11:59 a.m.